Results 221 to 230 of about 104,112 (336)

Exploring the 3D Bioprinting Landscape in the Delivery of Active Pharmaceutical Compounds for Therapeutic and Regenerative Medicine Applications

Journal of Biomedical Materials Research Part B: Applied Biomaterials, Volume 113, Issue 10, October 2025.
Three‐dimensional (3D) bioprinting is revolutionizing drug delivery and regenerative medicine by enabling personalized, controlled‐release therapeutic systems. This review explores advancements in biocompatible bioinks, nanomedicines, and 3D‐printed drug delivery constructs, including scaffolds, implants, and bioactive hydrogels.
Khonzisizwe Somandi, Yahya E. Choonara
wiley   +1 more source

Cardiac Autonomic Measures Predict Clinician-Rated Anxiety and Behavioral Response to Propranolol in Autistic Children and Young Adults. [PDF]

J Pers Med
Appling C, Nuraini N, Holem R, Hunter S, Hirst K, Takahashi N, Mazurek MO, Kanne SM, Ferguson B, Beversdorf DQ.   +9 more
europepmc   +1 more source

Experimental observations on propranolol in anaesthesia [PDF]

, 1969
Gerald B. H. Lewis
openalex   +1 more source

G Protein‐Coupled Receptor Signaling: Implications and Therapeutic Development Advances in Cancers

MedComm, Volume 6, Issue 10, October 2025.
G protein‐coupled receptors (GPCRs) are the dynamic protein family in the human genome. GPCR dysregulation aids in the advancement of cancer through increased migration, survival, and proliferation. Novel treatments that target GPCR signaling include orthosteric ligands, biased receptor mutants, PROTACs, and antibody–drug conjugates.
Inamu Rashid Khan, Sana Khurshid, Saud Almawash, Rakesh Kumar, Ammira S. Al‐Shabeeb Akil, Ajaz A. Bhat, Muzafar A. Macha   +6 more
wiley   +1 more source

Towards a Customized Oral Drug Therapy for Pediatric Applications: Chewable Propranolol Gel Tablets Printed by an Automated Extrusion-Based Material Deposition Method. [PDF]

Pharmaceutics
Roostar K, Meos A, Laidmäe I, Aruväli J, Räikkönen H, Peltonen L, Airaksinen S, Topelius NS, Heinämäki J, Paaver U.   +9 more
europepmc   +1 more source

Tinnitus and Propranolol [PDF]

BMJ, 1969
openaire   +3 more sources

Secular Trends in the Use of Valproate‐Containing Medicines in Women of Childbearing Age in Europe: A Multinational DARWIN EU Network Study

Pharmacoepidemiology and Drug Safety, Volume 34, Issue 10, October 2025.
ABSTRACT Background Valproate‐containing medicines (VPA) are first‐line treatments for epilepsy; however, they pose teratogenic risks, restricting their use in women of childbearing age. We aimed to estimate the secular trends in the use of VPA and alternative treatments in young women, and to characterise dose/strength, treatment duration, and ...
Lucía Bellas, Martí Català, Edward Burn, Yuchen Guo, Mike Du, Katia Verhamme, Egil Fridgeirsson, Talita Duarte‐Salles, Tommi Kauko, Eeva Kronqvist, James T. Brash, Sarah Seager, Daniel Prieto‐Alhambra, Annika M. Jödicke, Albert Prats‐Uribe   +14 more
wiley   +1 more source

Natural killer cells from endurance-trained older adults show improved functional and metabolic responses to adrenergic blockade and mTOR inhibition. [PDF]

Sci Rep
Minuzzi LG, Batatinha H, Weyh C, Balasubramanian Lakshmi VS, Fiuza-Luces C, Gálvez BG, Lucia A, Teixeira AM, Sommer N, Rosa-Neto JC, Lira FS, Krüger K.   +11 more
europepmc   +1 more source

Propranolol [PDF]

, 2020
openaire   +1 more source

Does propranolol have a role in cancer treatment? A systematic review of the epidemiological and clinical trial literature on beta-blockers. [PDF]

J Cancer Res Clin Oncol
O'Logbon J, Tarantola L, Williams NR, Mehta S, Ahmed A, Davies EA.   +5 more
europepmc   +1 more source